GEP20074048B - Sustained-release tablet composition of pramipexole - Google Patents

Sustained-release tablet composition of pramipexole

Info

Publication number: GEP20074048B
Authority: GE; Georgia
Prior art keywords: pramipexole; sustained; release tablet; tablet composition; composition
Prior art date: 2002-07-25

Application number

GEAP8599A

Other languages

English (en)

Inventor

Gregory E Amidon

Loksidh D Ganorkar

John M Heimlich

Ernest J Lee

Robert M Noack

Joseph P Reo

Connie J Skoug

Original Assignee

Pharmacia Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-25

Filing date

2003-07-25

Publication date

2007-02-26

2003-07-25 Application filed by Pharmacia Corp filed Critical Pharmacia Corp

2007-02-26 Publication of GEP20074048B publication Critical patent/GEP20074048B/en

Links

239000000203 mixture Substances 0.000 title abstract 2
FASDKYOPVNHBLU-ZETCQYMHSA-N pramipexole Chemical group C1[C@@H](NCCC)CCC2=C1SC(N)=N2 FASDKYOPVNHBLU-ZETCQYMHSA-N 0.000 title abstract 2
229960003089 pramipexole Drugs 0.000 title abstract 2
239000007939 sustained release tablet Substances 0.000 title 1
229920002472 Starch Polymers 0.000 abstract 1
229920001477 hydrophilic polymer Polymers 0.000 abstract 1
239000011159 matrix material Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
235000019698 starch Nutrition 0.000 abstract 1
239000008107 starch Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)

GEAP8599A 2002-07-25 2003-07-25 Sustained-release tablet composition of pramipexole GEP20074048B (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US39842702P	2002-07-25	2002-07-25
US39844702P	2002-07-25	2002-07-25
US47951303P	2003-06-18	2003-06-18

Publications (1)

Publication Number	Publication Date
GEP20074048B true GEP20074048B (en)	2007-02-26

Family

ID=31192087

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GEAP8599A GEP20074048B (en)	2002-07-25	2003-07-25	Sustained-release tablet composition of pramipexole

Country Status (40)

Country	Link
US (2)	US20050226926A1 (pt)
EP (2)	EP1531814B1 (pt)
JP (1)	JP4700963B2 (pt)
KR (1)	KR100712832B1 (pt)
CN (1)	CN1313092C (pt)
AP (1)	AP2201A (pt)
AR (1)	AR040681A1 (pt)
AT (1)	ATE406162T1 (pt)
AU (1)	AU2003261241B2 (pt)
BR (1)	BR0312960A (pt)
CA (1)	CA2492854C (pt)
CR (1)	CR7661A (pt)
CU (1)	CU23440B7 (pt)
CY (1)	CY1110408T1 (pt)
DE (1)	DE60323235D1 (pt)
DK (1)	DK1531814T3 (pt)
EA (2)	EA200702187A1 (pt)
EC (1)	ECSP055568A (pt)
ES (1)	ES2310673T3 (pt)
GE (1)	GEP20074048B (pt)
HR (1)	HRP20041235B1 (pt)
IL (1)	IL166078A0 (pt)
IS (1)	IS7623A (pt)
MA (1)	MA27328A1 (pt)
ME (1)	MEP52308A (pt)
MX (1)	MXPA05001054A (pt)
MY (1)	MY138846A (pt)
NO (1)	NO334298B1 (pt)
NZ (1)	NZ537790A (pt)
OA (1)	OA13303A (pt)
PA (1)	PA8578301A1 (pt)
PE (1)	PE20040130A1 (pt)
PL (1)	PL215587B1 (pt)
PT (1)	PT1531814E (pt)
RS (1)	RS51719B (pt)
SI (1)	SI1531814T1 (pt)
TW (1)	TWI347849B (pt)
UY (1)	UY27912A1 (pt)
WO (1)	WO2004010997A1 (pt)
ZA (1)	ZA200500439B (pt)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060281797A1 (en) *	2001-12-11	2006-12-14	University Of Virginia Patent Foundation	Neurorestoration with R(+) Pramipexole
ES2432527T3 (es) *	2001-12-11	2013-12-04	University Of Virginia Patent Foundation	Uso de pramipexol para tratar la esclerosis lateral amiotrófica
US20050226926A1 (en)	2002-07-25	2005-10-13	Pfizer Inc	Sustained-release tablet composition of pramipexole
PA8578501A1 (es) *	2002-07-25	2005-02-04	Pharmacia Corp	Forma de dosificacion una vez al dia de pramipexol
US20070196481A1 (en) *	2002-07-25	2007-08-23	Amidon Gregory E	Sustained-release tablet composition
US9101155B2 (en)	2003-07-11	2015-08-11	Asahi Kasei Chemicals Corporation	Functional starch powder
UA93608C2 (ru) *	2004-08-13	2011-02-25	Берингер Ингельхайм Интернациональ Гмбх	композициЯ таблетки пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, СПОСОБ EE ИЗГОТОВЛЕНИЯ И EE ПРИМЕНЕНИЕ
CN101022788B (zh) *	2004-08-13	2010-11-10	贝林格尔·英格海姆国际有限公司	包含普拉克索或其可药用盐的延长释放小球制剂、其制备方法及其用途
DE602004022205D1 (de) *	2004-09-09	2009-09-03	Psicofarma S A De C V	Pharmazeutische zusammensetzung für die verzögerte freisetzung von hydralazin und ihre verwendung als unterstützung zur krebstherapie
EP1731514A1 (en) *	2005-06-02	2006-12-13	Sandoz AG	Process for the preparation of Pramipexole
ATE444750T1 (de) *	2005-08-15	2009-10-15	Univ Virginia	Neurorestauration mit r(+) pramipexol
WO2007090883A1 (en) *	2006-02-10	2007-08-16	Boehringer Ingelheim International Gmbh	Extended release formulation
EP1988875A2 (en) *	2006-02-10	2008-11-12	Boehringer Ingelheim International GmbH	Modified release formulation
WO2007090882A2 (en) *	2006-02-10	2007-08-16	Boehringer Ingelheim International Gmbh	Pharmaceutical extended release compositions comprising pramipexole
US8518926B2 (en)	2006-04-10	2013-08-27	Knopp Neurosciences, Inc.	Compositions and methods of using (R)-pramipexole
US20070259930A1 (en) *	2006-04-10	2007-11-08	Knopp Neurosciences, Inc.	Compositions and methods of using r(+) pramipexole
ATE537826T1 (de)	2006-05-16	2012-01-15	Knopp Neurosciences Inc	Zusammensetzungen aus r(+)- und s(-)-pramipexol sowie verfahren zu ihrer anwendung
WO2008001204A2 (en) *	2006-06-29	2008-01-03	Antares Pharma Ipl Ag	Transdermal compositions of pramipexole having enhanced permeation properties
US8524695B2 (en) *	2006-12-14	2013-09-03	Knopp Neurosciences, Inc.	Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
JP2010521496A (ja)	2007-03-14	2010-06-24	ノップニューロサイエンシーズ、インク．	キラル精製置換ベンゾチアゾールジアミンの合成
US20100092554A1 (en) *	2007-04-24	2010-04-15	Boehringer Ingelheim International Gmbh	Combination with an extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
WO2008150741A1 (en) *	2007-06-04	2008-12-11	Drugtech Corporation	Controlled release dopamine agonist compositions
EP2291178A4 (en) *	2008-06-09	2013-07-24	Supernus Pharmaceuticals Inc	PRAMIPEXOL FORMULATIONS WITH CONTROLLED RELEASE
US20110190356A1 (en)	2008-08-19	2011-08-04	Knopp Neurosciences Inc.	Compositions and Methods of Using (R)- Pramipexole
AU2010262970A1 (en) *	2009-06-19	2012-01-12	Knopp Neurosciences, Inc.	Compositions and methods for treating amyotrophic lateral sclerosis
EP2448411A4 (en) *	2009-07-02	2012-11-28	Supernus Pharmaceuticals Inc	METHOD OF TREATING A NEUROLOGICAL DISORDER
WO2011037976A2 (en) *	2009-09-22	2011-03-31	Dr. Reddy's Laboratories Limited	Pramipexole pharmaceutical formulations
EP2525786A2 (en)	2010-01-18	2012-11-28	Synthon BV	Pramipexole extended release tablets
TR201001862A1 (tr)	2010-03-11	2011-10-21	Sanovel �La� San.Ve T�C.A.�.	Kontrollü salım gerçekleştiren pramipeksol formülasyonları.
JP2013526601A (ja)	2010-05-24	2013-06-24	ルピン・リミテッド	プラミペキソールの徐放性製剤
KR101307334B1 (ko) *	2010-07-02	2013-09-12	주식회사 바이오파마티스	프라미펙솔 또는 이의 약학적으로 허용되는 염을 포함하는 안정성이 개선된 서방형 약학 조성물
WO2013034173A1 (en)	2011-09-06	2013-03-14	Synthon Bv	Pramipexole extended release tablets
WO2013096816A1 (en)	2011-12-22	2013-06-27	Biogen Idec Ma Inc.	Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
EP2732812A1 (de)	2012-11-15	2014-05-21	Aristo Pharma GmbH	Pramipexol-Retardtablettenformulierung
US9662313B2 (en)	2013-02-28	2017-05-30	Knopp Biosciences Llc	Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9468630B2 (en)	2013-07-12	2016-10-18	Knopp Biosciences Llc	Compositions and methods for treating conditions related to increased eosinophils
PL3019167T3 (pl)	2013-07-12	2021-06-14	Knopp Biosciences Llc	Leczenie podwyższonych poziomów eozynofili i/lub bazofili
EP3038467B1 (en)	2013-08-13	2020-07-29	Knopp Biosciences LLC	Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
DK3033081T3 (da)	2013-08-13	2021-05-31	Knopp Biosciences Llc	Sammensætninger og fremgangsmåder til behandling af kronisk urticaria
CN103520128B (zh)	2013-10-12	2018-08-21	石家庄杏林锐步医药科技股份有限公司	一种普拉克索的缓释片剂、制备方法及其用途
IL312486B2 (en)	2017-04-10	2025-05-01	Chase Therapeutics Corp	NK1 antagonist combination and method for treating synucleinopathies
CN110719778B (zh)	2017-04-24	2024-06-18	才思治疗公司	用于治疗抑郁的组合物和方法
CA3104811C (en)	2017-06-30	2024-05-28	Chase Therapeutics Corporation	Composition comprising pramipexole and nk1-antagonists for treating depression
CN109316466B (zh) *	2017-07-31	2022-04-05	深圳翰宇药业股份有限公司	一种盐酸普拉克索缓释制剂及其制备方法
US11234961B2 (en)	2017-08-17	2022-02-01	Zi-Qiang Gu	Pamoate salt of monoamine anti-Parkinson's agents, method of preparation and use thereof
CN113876729B (zh) *	2021-11-11	2023-05-30	南通联亚药业股份有限公司	一种盐酸普拉克索缓释片剂及其制备方法

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US15735A (en) *		1856-09-16		Improvement in harvesters
US2887440A (en) *	1957-08-12	1959-05-19	Dow Chemical Co	Enteric coating
US3845770A (en)	1972-06-05	1974-11-05	Alza Corp	Osmatic dispensing device for releasing beneficial agent
JPS58403B2 (ja)	1975-07-24	1983-01-06	武田薬品工業株式会社	Ｌ− アスコルビンサンセイザイノセイゾウホウ
US4140755A (en)	1976-02-13	1979-02-20	Hoffmann-La Roche Inc.	Sustained release tablet formulations
CH649215A5 (de)	1981-04-29	1985-05-15	Hoffmann La Roche	Pharmazeutische praeparate.
SE8103843L (sv)	1981-06-18	1982-12-19	Astra Laekemedel Ab	Farmaceutisk mixtur
US4424235A (en)	1981-09-14	1984-01-03	Hoffmann-La Roche Inc.	Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor
DE3447075A1 (de) *	1984-12-22	1986-07-03	Dr. Karl Thomae Gmbh, 7950 Biberach	Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arzneimittel
DE3572485D1 (en)	1984-12-22	1989-09-28	Thomae Gmbh Dr K	Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
US4738851A (en)	1985-09-27	1988-04-19	University Of Iowa Research Foundation, Inc.	Controlled release ophthalmic gel formulation
US4709712A (en)	1986-10-22	1987-12-01	Dermatalogical Products Of Texas	Polycarboxylic acid polymer gels as protective agents
GB8828020D0 (en)	1988-12-01	1989-01-05	Unilever Plc	Topical composition
US5026559A (en)	1989-04-03	1991-06-25	Kinaform Technology, Inc.	Sustained-release pharmaceutical preparation
US5133974A (en)	1989-05-05	1992-07-28	Kv Pharmaceutical Company	Extended release pharmaceutical formulations
KR0167346B1 (ko)	1989-06-09	1999-01-15	로버트 에이. 아미테이지	중추신경계 활성을 갖는 헤테로사이클릭 아민
US5273975A (en)	1989-06-09	1993-12-28	The Upjohn Company	Heterocyclic amines having central nervous system activity
GB9015822D0 (en)	1990-07-18	1990-09-05	Beecham Group Plc	Compositions
US5472712A (en) *	1991-12-24	1995-12-05	Euroceltique, S.A.	Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5656296A (en) *	1992-04-29	1997-08-12	Warner-Lambert Company	Dual control sustained release drug delivery systems and methods for preparing same
US5431920A (en)	1993-09-21	1995-07-11	Merck Frosst, Canada, Inc.	Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
US5458887A (en) *	1994-03-02	1995-10-17	Andrx Pharmaceuticals, Inc.	Controlled release tablet formulation
WO1997004752A1 (en) *	1995-07-26	1997-02-13	Duramed Pharmaceuticals, Inc.	Pharmaceutical compositions of conjugated estrogens and methods for their use
WO1998055107A1 (en)	1997-06-06	1998-12-10	Depomed, Inc.	Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs
CA2290966C (en)	1997-07-01	2005-12-20	Pfizer Inc.	Sertraline salts and sustained-release dosage forms of sertraline
US5895663A (en)	1997-07-31	1999-04-20	L. Perrigo Company	Pseudoephedrine hydrochloride extended-release tablets
CA2211778A1 (en) *	1997-08-14	1999-02-14	Francois Carriere	Preparation of pregelatinized high amylose starch and debranched starch useful as an excipient for controlled release of active agents
US7153845B2 (en)	1998-08-25	2006-12-26	Columbia Laboratories, Inc.	Bioadhesive progressive hydration tablets
US6624200B2 (en)	1998-08-25	2003-09-23	Columbia Laboratories, Inc.	Bioadhesive progressive hydration tablets
DE69819748T2 (de)	1997-09-12	2004-09-30	Columbia Laboratories (Bermuda) Ltd.	Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US6248358B1 (en)	1998-08-25	2001-06-19	Columbia Laboratories, Inc.	Bioadhesive progressive hydration tablets and methods of making and using the same
US6197339B1 (en) *	1997-09-30	2001-03-06	Pharmacia & Upjohn Company	Sustained release tablet formulation to treat Parkinson's disease
US6056977A (en) *	1997-10-15	2000-05-02	Edward Mendell Co., Inc.	Once-a-day controlled release sulfonylurea formulation
GB9802201D0 (en) *	1998-02-03	1998-04-01	Cerestar Holding Bv	Free-flowable directly compressible starch as binder,disintegrant and filler for compresion tablets and hard gelatine capsules
JP2002506031A (ja)	1998-03-11	2002-02-26	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	組成物
GB9812426D0 (en)	1998-06-10	1998-08-05	Reckitt & Colmann Prod Ltd	Improvements in or relating to organic compositions
TW407058B (en)	1998-07-17	2000-10-01	Dev Center Biotechnology	Oral cisapride dosage forms with an extended duration
DE19906290A1 (de)	1999-02-15	2000-08-17	Falk Pharma Gmbh	Arzneimittel zur Behandlung bzw. Prävention von Darmkrebs
US7374779B2 (en)	1999-02-26	2008-05-20	Lipocine, Inc.	Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
EP1169024B1 (en) *	1999-03-31	2005-12-21	Janssen Pharmaceutica N.V.	Pregelatinized starch in a controlled release formulation
DE19927688A1 (de)	1999-06-17	2000-12-21	Gruenenthal Gmbh	Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
DE60022692T2 (de)	1999-07-01	2006-06-22	Pharmacia & Upjohn Co. Llc, Kalamazoo	(S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
AP2002002410A0 (en)	1999-08-04	2002-03-31	Ranbaxy Laboratories Ltd	Hydrodynamically Balancing Oral Drug Delivery System
CO5210862A1 (es)	1999-09-15	2002-10-30	Alza Corp	Formas de dosificacion y metodos para proporcionar efectiva terapia de reboxetina con dosificacion de una vez al dia
CA2384840A1 (en)	1999-09-30	2001-04-05	The General Hospital Corporation	Use of pramipexole as a treatment for cocaine craving
US20030180352A1 (en) *	1999-11-23	2003-09-25	Patel Mahesh V.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CN1434713A (zh) *	1999-12-22	2003-08-06	法马西亚公司	环加氧酶－2抑制剂的缓释制剂
US6467637B2 (en)	2000-01-27	2002-10-22	The York Group, Inc.	Death care merchandising system
PT1257277E (pt)	2000-02-24	2005-09-30	Pharmacia & Upjohn Co Llc	Novas combinacoes de farmacos
US6277875B1 (en) *	2000-07-17	2001-08-21	Andrew J. Holman	Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
ES2187249B1 (es)	2000-09-18	2004-09-16	Synthon Bv	Procedimiento para la preparacion de 2-amino-6-(alquil)amino-4,5,6,7-tetrahidrobenzotiazoles.
SE0004671D0 (sv)	2000-12-15	2000-12-15	Amarin Dev Ab	Pharmaceutical formulation
DE10138275A1 (de)	2001-08-10	2003-02-27	Boehringer Ingelheim Pharma	Verbindungen zur Beseitigung der Anhedonie
CA2470636A1 (en)	2001-12-20	2003-07-03	Pharmacia Corporation	Zero-order sustained released dosage forms and method of making the same
BR0312876A (pt)	2002-07-25	2005-06-28	Pharmacia Corp	Método de preparação de formas de dosagem sólidas revestidas em duas camadas compreendendo um polìmero insolúvel em água e um agente formador de poros solúvel em água
PA8578501A1 (es)	2002-07-25	2005-02-04	Pharmacia Corp	Forma de dosificacion una vez al dia de pramipexol
US20070196481A1 (en)	2002-07-25	2007-08-23	Amidon Gregory E	Sustained-release tablet composition
US20050226926A1 (en)	2002-07-25	2005-10-13	Pfizer Inc	Sustained-release tablet composition of pramipexole
US20040121010A1 (en)	2002-10-25	2004-06-24	Collegium Pharmaceutical, Inc.	Pulsatile release compositions of milnacipran
WO2004080440A1 (en)	2003-03-11	2004-09-23	Korea United Pharm, Inc.	Process for the preparing of hardcapsule formulation containing lansoprazole
MXPA05010636A (es)	2003-04-04	2005-12-12	Pharmacia Corp	Comprimidos de multiparticulas preparados por compresion de liberacion oral prolongada.
US20050020589A1 (en)	2003-06-18	2005-01-27	Pfizer Inc.	Sustained-release tablet composition comprising a dopamine receptor agonist
CN101022788B (zh)	2004-08-13	2010-11-10	贝林格尔·英格海姆国际有限公司	包含普拉克索或其可药用盐的延长释放小球制剂、其制备方法及其用途
UA93608C2 (ru)	2004-08-13	2011-02-25	Берингер Ингельхайм Интернациональ Гмбх	композициЯ таблетки пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, СПОСОБ EE ИЗГОТОВЛЕНИЯ И EE ПРИМЕНЕНИЕ
WO2006046256A1 (en)	2004-10-27	2006-05-04	Alembic Limited	Extended release formulation of pramipexole dihydrochloride
WO2007002518A1 (en)	2005-06-23	2007-01-04	Spherics, Inc.	Delayed release or extended-delayed release dosage forms of pramipexole
CA2613631A1 (en)	2005-06-23	2007-01-04	Spherics, Inc.	Improved dosage forms for movement disorder treatment
ATE444750T1 (de)	2005-08-15	2009-10-15	Univ Virginia	Neurorestauration mit r(+) pramipexol
WO2007054976A2 (en)	2005-11-08	2007-05-18	Panacea Biotec Ltd.	Lipid based controlled release pharmaceutical composition
EP1988875A2 (en)	2006-02-10	2008-11-12	Boehringer Ingelheim International GmbH	Modified release formulation
WO2007090883A1 (en)	2006-02-10	2007-08-16	Boehringer Ingelheim International Gmbh	Extended release formulation
WO2007090882A2 (en)	2006-02-10	2007-08-16	Boehringer Ingelheim International Gmbh	Pharmaceutical extended release compositions comprising pramipexole
EP1886665A1 (en)	2006-08-01	2008-02-13	Boehringer Ingelheim Pharma GmbH & Co. KG	Gastro retentive delivery system

2003
- 2003-07-23 US US10/626,166 patent/US20050226926A1/en not_active Abandoned
- 2003-07-24 AR AR20030102666A patent/AR040681A1/es unknown
- 2003-07-24 PA PA20038578301A patent/PA8578301A1/es unknown
- 2003-07-24 MY MYPI20032784A patent/MY138846A/en unknown
- 2003-07-24 PE PE2003000734A patent/PE20040130A1/es not_active Application Discontinuation
- 2003-07-25 DE DE60323235T patent/DE60323235D1/de not_active Expired - Lifetime
- 2003-07-25 PT PT03771807T patent/PT1531814E/pt unknown
- 2003-07-25 OA OA1200500016A patent/OA13303A/en unknown
- 2003-07-25 AP AP2005003205A patent/AP2201A/xx active
- 2003-07-25 AU AU2003261241A patent/AU2003261241B2/en not_active Ceased
- 2003-07-25 GE GEAP8599A patent/GEP20074048B/en unknown
- 2003-07-25 PL PL375696A patent/PL215587B1/pl unknown
- 2003-07-25 JP JP2004524787A patent/JP4700963B2/ja not_active Expired - Fee Related
- 2003-07-25 SI SI200331350T patent/SI1531814T1/sl unknown
- 2003-07-25 ME MEP-523/08A patent/MEP52308A/xx unknown
- 2003-07-25 CA CA002492854A patent/CA2492854C/en not_active Expired - Fee Related
- 2003-07-25 TW TW092120406A patent/TWI347849B/zh not_active IP Right Cessation
- 2003-07-25 EP EP03771807A patent/EP1531814B1/en not_active Expired - Lifetime
- 2003-07-25 ES ES03771807T patent/ES2310673T3/es not_active Expired - Lifetime
- 2003-07-25 EA EA200702187A patent/EA200702187A1/ru unknown
- 2003-07-25 MX MXPA05001054A patent/MXPA05001054A/es active IP Right Grant
- 2003-07-25 KR KR1020057001392A patent/KR100712832B1/ko not_active Expired - Fee Related
- 2003-07-25 NZ NZ537790A patent/NZ537790A/en unknown
- 2003-07-25 BR BR0312960-8A patent/BR0312960A/pt not_active IP Right Cessation
- 2003-07-25 CN CNB038178737A patent/CN1313092C/zh not_active Expired - Fee Related
- 2003-07-25 HR HRP20041235AA patent/HRP20041235B1/hr not_active IP Right Cessation
- 2003-07-25 EP EP08159203A patent/EP1987832A1/en not_active Withdrawn
- 2003-07-25 WO PCT/US2003/023205 patent/WO2004010997A1/en not_active Ceased
- 2003-07-25 DK DK03771807T patent/DK1531814T3/da active
- 2003-07-25 AT AT03771807T patent/ATE406162T1/de active
- 2003-07-25 RS YU20050059A patent/RS51719B/sr unknown
- 2003-07-25 EA EA200500079A patent/EA009663B1/ru not_active IP Right Cessation
- 2003-07-31 UY UY27912A patent/UY27912A1/es not_active Application Discontinuation
2004
- 2004-12-29 IS IS7623A patent/IS7623A/is unknown
- 2004-12-30 IL IL16607804A patent/IL166078A0/xx unknown
2005
- 2005-01-06 NO NO20050093A patent/NO334298B1/no not_active IP Right Cessation
- 2005-01-17 ZA ZA200500439A patent/ZA200500439B/xx unknown
- 2005-01-24 EC EC2005005568A patent/ECSP055568A/es unknown
- 2005-01-24 CR CR7661A patent/CR7661A/es unknown
- 2005-01-25 MA MA28066A patent/MA27328A1/fr unknown
- 2005-01-25 CU CU20050018A patent/CU23440B7/es not_active IP Right Cessation
2008
- 2008-10-13 CY CY20081101125T patent/CY1110408T1/el unknown
2010
- 2010-03-03 US US12/716,755 patent/US8399016B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
PA8578301A1 (es)	2004-07-20
MA27328A1 (fr)	2005-05-02
EP1531814B1 (en)	2008-08-27
UY27912A1 (es)	2004-02-27
NZ537790A (en)	2005-10-28
ZA200500439B (en)	2006-08-30
NO20050093L (no)	2005-02-24
TWI347849B (en)	2011-09-01
AP2201A (en)	2011-01-24
HRP20041235A2 (en)	2005-06-30
EA200702187A1 (ru)	2008-06-30
EP1987832A1 (en)	2008-11-05
JP4700963B2 (ja)	2011-06-15
CN1313092C (zh)	2007-05-02
OA13303A (en)	2007-04-13
DK1531814T3 (da)	2008-10-13
EA200500079A1 (ru)	2005-06-30
WO2004010997A8 (en)	2005-02-24
PL375696A1 (en)	2005-12-12
SI1531814T1 (sl)	2008-12-31
US8399016B2 (en)	2013-03-19
ES2310673T3 (es)	2009-01-16
ATE406162T1 (de)	2008-09-15
RS20050059A (sr)	2007-08-03
MEP52308A (en)	2011-02-10
AU2003261241B2 (en)	2009-06-18
MY138846A (en)	2009-07-31
ECSP055568A (es)	2005-04-18
RS51719B (sr)	2011-10-31
EP1531814A1 (en)	2005-05-25
CR7661A (es)	2005-06-08
JP2005538106A (ja)	2005-12-15
IS7623A (is)	2004-12-29
CA2492854C (en)	2009-10-20
US20050226926A1 (en)	2005-10-13
BR0312960A (pt)	2005-06-14
CY1110408T1 (el)	2015-04-29
HK10777456A1 (en)	2007-11-30
AP2005003205A0 (en)	2005-03-31
PE20040130A1 (es)	2004-03-06
MXPA05001054A (es)	2005-04-08
KR100712832B1 (ko)	2007-04-30
AU2003261241A1 (en)	2004-02-16
AR040681A1 (es)	2005-04-13
DE60323235D1 (de)	2008-10-09
PL215587B1 (pl)	2013-12-31
TW200418523A (en)	2004-10-01
PT1531814E (pt)	2008-10-29
WO2004010997A1 (en)	2004-02-05
EA009663B1 (ru)	2008-02-28
KR20050062516A (ko)	2005-06-23
IL166078A0 (en)	2006-01-15
US20100316710A1 (en)	2010-12-16
CU23440B7 (es)	2009-10-16
CN1671382A (zh)	2005-09-21
NO334298B1 (no)	2014-01-27
CA2492854A1 (en)	2004-02-05
HRP20041235B1 (hr)	2013-07-31

Publication	Publication Date	Title
GEP20074048B (en)	2007-02-26	Sustained-release tablet composition of pramipexole
TW200618821A (en)	2006-06-16	Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
ATE268593T1 (de)	2004-06-15	Bupropionhydrochlorid enthaltende tabletten mit gesteuerter wirkstoffabgabe
NO20021013D0 (no)	2002-02-28	Vandig geldannet blanding som omfatter en blokk-kopolymer inkluderende minst en vannopplöselig blokk og en hydrofob blokk
MY136318A (en)	2008-09-30	Sustained-release tablet composition
CA2474722A1 (en)	2003-08-14	Coated clumping litter
NO20045018L (no)	2004-11-18	Bohmittpartikler og polymermaterialer omfattende slike
IL166747A (en)	2010-11-30	Water-soluble iron-carbohydrate complexes, production thereof and medicaments containing said complexes
MX2007005724A (es)	2007-07-09	Articulo para tratamiento cosmetico que comprende un sustrato y una composicion en gel.
GR20010300049T1 (en)	2001-09-28	Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
AU2003253719A1 (en)	2003-09-29	Active matrix display devices, and their manufacture
AU6447500A (en)	2001-01-09	Solid aqueous gel comprising a hydrophilic gelling agent and starch, compositioncomprising same and uses
MXPA02012851A (es)	2003-09-05	Pirrolidinas 1,3-disustituidas y 1,3,3-trisustituidas como ligandos del receptor de histamina-3 y sus aplicaciones terapeuticas.
NO20076108L (no)	2008-02-15	Gelatin-inneholdende topikal sammensetning
AU2003213159A1 (en)	2003-09-22	Automated supply, load and take-away systems
CA102879S (en)	2004-10-26	Loud speaker
AR038206A1 (es)	2005-01-05	Composicion farmaceutica dispersable oralmente de ivabradina
EP0859597A4 (pt)	1998-10-07
AU2003254566A1 (en)	2004-02-09	Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
WO2004096155A3 (en)	2005-04-07	Tablets and methods for modified release of hydrophilic and other active agents
CA101943S (en)	2004-02-25	Plate
AU2003275127A1 (en)	2004-04-08	P. ariasi polypeptides, p. perniciosus polypeptides and methods of use
RU2003103720A (ru)	2004-07-27	Штамм бактерий bacillus pantothenticus 1-85 для использования в гранулированных кормах
WO2007012859A3 (en)	2007-04-26	Denture support composition
AU2003240743A1 (en)	2003-12-31	Deoxyhypusine-synthase inhibitors, pharmaceuticals comprising said inhibitors and uses thereof